Join CNC Ms Mary Roberts as she examines COPD in Australia, and provides some quality advice on what you can do to control breathlessness and ensure the best possible quality of life for your patients, in alignment with World COPD Day 2018.
This Quality Improvement (QI) Program aims to improve the management of patients with chronic heart failure with a LVEF (left ventricular ejection fraction) lower than 40%.
Insomnia is the most common sleep disorder seen in primary care, accounting for 8 out of 10 sleep disorders. Australian population surveys show that up to one third of adults have regular difficulty in getting to sleep or staying asleep. Despite its frequent presentation, the management of insomnia is said to be suboptimal due to under recognition of the disorder as well as inadequate treatment strategies. This activity will help GPs understand the impact of insomnia, how to identify insomnia and how to approach treatment.
Heart failure is a significant health issue in Australia, with complex diagnostic and management methods that must be tailored to each patient. This ALM comprehensively covers the many stages of heart failure management including the identification of risk factors, diagnosis and investigations, pharmacological and non-pharmacological management, management of progression and comorbidities, the use of implantable devices and end-of-life care, and multidisciplinary care programs.
Heart failure is a significant health issue in Australia with a mortality rate comparable to the common forms of cancer, but early detection and management can significantly improve patient outcomes. This module outlines the signs and symptoms of heart failure, and the screening of individuals with increased risk factors.
This is one module in the Heart Failure in General Practice series.
Click here to view all modules in this series.
Early investigation is critical to determining the cause of heart failure, its mechanism and any exacerbating factors, allowing for management to be optimised for each patient. This module explores the diagnostic investigations essential for heart failure including echocardiography, ECG, chest X-ray and blood tests, as well as guidance on interpreting results.
Pharmacological therapies are central to both the prevention of heart failure in high risk groups and the ongoing management of existing HF. This module covers the evidence-based pharmacological therapies for heart failure and the management of the risk of HF progression.
